Agency Information Collection Activities; Proposed Collection; Unique Device Identification System; Extension of Comment Period, 57055 [2012-22821]

Download as PDF Federal Register / Vol. 77, No. 180 / Monday, September 17, 2012 / Proposed Rules the animal, where the revenue from the sale of apparel or fur products is not the primary source of income of such person. 13. Amend § 301.41 by removing paragraph (a)(7) and by revising paragraph (a)(4) to read as follows: § 301.41 Maintenance of Records. (a) * * * (4) That the fur product is composed in whole or in substantial part of paws, tails, bellies, gills, ears, throats, heads, scrap pieces, or waste fur, when such is the fact; * * * * * By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2012–22568 Filed 9–14–12; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 16, 801, 803, 806, 810, 814, 820, 821, 822, and 830 [Docket No. FDA–2011–N–0090] RIN 0910–AG31 Agency Information Collection Activities; Proposed Collection; Unique Device Identification System; Extension of Comment Period AGENCY: mark your comment to the FDA desk officer and reference this rule. FOR FURTHER INFORMATION CONTACT: Jay Crowley, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301– 796–5995, email: cdrhudi@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of July 10, 2012 (77 FR 40736), FDA published a notice of proposed rulemaking with a 60-day comment period concerning the proposed information collection. Comments on the proposed rulemaking will inform FDA’s rulemaking to establish regulations for Unique Device Identification System. The Agency has received requests for a 45-day extension of the comment period for the information collection. Each request conveyed concern that the current 60-day comment period does not allow sufficient time to develop a meaningful or thoughtful response to the information collection. FDA has considered the requests and is extending the comment period for the information collection for 45 days, until October 25, 2012. The Agency believes that a 45-day extension allows adequate time for interested persons to submit comments without significantly delaying rulemaking on these important issues. sroberts on DSK5SPTVN1PROD with PROPOSALS [FR Doc. 2012–22793 Filed 9–14–12; 8:45 am] The Food and Drug Administration (FDA) is extending the comment period pertaining to information collection issues under the Paperwork Reduction Act of 1995 (the PRA) associated with the proposed rule, Unique Device Identification System, that appeared in the Federal Register of July 10, 2012 (77 FR 40736). The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. DATES: Submit either electronic or written comments on the proposed collection of information by October 25, 2012. ADDRESSES: Submit electronic comments on the collection of information to the Office of Regulatory Affairs, Office of Management and Budget (OMB) at FAX: 202–395–7285, or email comments to OIRA_submissions@omb.eop.gov. Please Dated: September 12, 2012. Leslie Kux, Assistant Commissioner for Policy. BILLING CODE 4160–01–P DEPARTMENT OF THE TREASURY Office of the Secretary SUMMARY: Jkt 226001 Dated: September 11, 2012. Leslie Kux, Assistant Commissioner for Policy. BILLING CODE 4160–01–P Notification; extension of comment period. ACTION: 17:54 Sep 14, 2012 Review: Solutions for Study Data Exchange Standards.’’ The document was published with an incorrect email address. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Ron Fitzmartin, Office of Planning & Informatics, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 1160, Silver Spring, MD 20993–0002, 301–796–5333, FAX: 301–847–8443, email: CDERDataStandards@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In FR Doc. 2012–19748, appearing on page 48491 in the Federal Register of August 14, 2012, the following corrections are made: 1. On page 48491, in the first column, in the FOR FURTHER INFORMATION CONTACT section, the email address ‘‘CDERDataStandards@hhs.fda.gov’’ is corrected to read ‘‘CDERDataStandards@fda.hhs.gov.’’ 2. On page 48491, in the second column, in the SUPPLEMENTARY INFORMATION section, under ‘‘Registration,’’ the email address ‘‘CDERDataStandards@hhs.fda.gov’’ is corrected to read ‘‘CDERDataStandards@fda.hhs.gov.’’ [FR Doc. 2012–22821 Filed 9–14–12; 8:45 am] Food and Drug Administration, HHS. VerDate Mar<15>2010 57055 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 31 CFR Part 10 [REG–138367–06] RIN 1545–BF96 21 CFR Chapter I Regulations Governing Practice Before the Internal Revenue Service [Docket No. FDA–2012–N–0780] AGENCY: Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Notice of Meeting; Request for Comments; Correction AGENCY: Food and Drug Administration, HHS. Announcement of meeting; request for comments; correction. ACTION: The Food and Drug Administration (FDA) is correcting a document that appeared in the Federal Register of August 14, 2012 (77 FR 48491). The document announced a meeting entitled ‘‘Regulatory New Drug SUMMARY: PO 00000 Frm 00019 Fmt 4702 Sfmt 4702 Office of the Secretary, Treasury. ACTION: Withdrawal of notice of proposed rulemaking; notice of proposed rulemaking and notice of public hearing. This document proposes modifications of the regulations governing practice before the Internal Revenue Service (IRS). These proposed regulations affect individuals who practice before the IRS. These proposed regulations modify the standards governing written advice and update certain provisions as appropriate. This document also provides notice of a SUMMARY: E:\FR\FM\17SEP1.SGM 17SEP1

Agencies

[Federal Register Volume 77, Number 180 (Monday, September 17, 2012)]
[Proposed Rules]
[Page 57055]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22821]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 16, 801, 803, 806, 810, 814, 820, 821, 822, and 830

[Docket No. FDA-2011-N-0090]
RIN 0910-AG31


Agency Information Collection Activities; Proposed Collection; 
Unique Device Identification System; Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notification; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending the 
comment period pertaining to information collection issues under the 
Paperwork Reduction Act of 1995 (the PRA) associated with the proposed 
rule, Unique Device Identification System, that appeared in the Federal 
Register of July 10, 2012 (77 FR 40736). The Agency is taking this 
action in response to requests for an extension to allow interested 
persons additional time to submit comments.

DATES: Submit either electronic or written comments on the proposed 
collection of information by October 25, 2012.

ADDRESSES: Submit electronic comments on the collection of information 
to the Office of Regulatory Affairs, Office of Management and Budget 
(OMB) at FAX: 202-395-7285, or email comments to OIRA_submissions@omb.eop.gov. Please mark your comment to the FDA desk 
officer and reference this rule.

FOR FURTHER INFORMATION CONTACT: Jay Crowley, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Silver Spring, MD 20993, 301-796-5995, email: 
cdrhudi@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: 

I. Background

    In the Federal Register of July 10, 2012 (77 FR 40736), FDA 
published a notice of proposed rulemaking with a 60-day comment period 
concerning the proposed information collection. Comments on the 
proposed rulemaking will inform FDA's rulemaking to establish 
regulations for Unique Device Identification System.
    The Agency has received requests for a 45-day extension of the 
comment period for the information collection. Each request conveyed 
concern that the current 60-day comment period does not allow 
sufficient time to develop a meaningful or thoughtful response to the 
information collection.
    FDA has considered the requests and is extending the comment period 
for the information collection for 45 days, until October 25, 2012. The 
Agency believes that a 45-day extension allows adequate time for 
interested persons to submit comments without significantly delaying 
rulemaking on these important issues.

    Dated: September 12, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-22821 Filed 9-14-12; 8:45 am]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.